Antaros Medical is pioneering imaging methodologies to design and deliver clinical imaging studies for improved, evidence-based decision making in drug development. The company is specialized in cardio-metabolic diseases (incl NAFLD/NASH) and oncology. The company has today a global network of collaboration partners and customers, including both big and small drug developing companies, and is a partner in several European collaboration initiatives eg Innovative Medicines Initiative (IMI).
IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 55,000 employees worldwide. Learn more at https://www.iqvia.com/our-customers/emerging-biopharma
George Clinical is the leading Asia-Pacific based global full service CRO and has established a reputation as the partner of choice for the execution of renal studies. Global scientific leadership is at the core of what we do and is led by Vlado Perkovic, Executive Director, The George Institute. Leveraging this leadership, George Clinical is able to assist clients in the design of effective studies and the identification of quality investigators that deliver accelerated recruitment.